JP2004514412A - 卵巣癌のための治療化合物 - Google Patents

卵巣癌のための治療化合物 Download PDF

Info

Publication number
JP2004514412A
JP2004514412A JP2002500918A JP2002500918A JP2004514412A JP 2004514412 A JP2004514412 A JP 2004514412A JP 2002500918 A JP2002500918 A JP 2002500918A JP 2002500918 A JP2002500918 A JP 2002500918A JP 2004514412 A JP2004514412 A JP 2004514412A
Authority
JP
Japan
Prior art keywords
cells
cell
peptide
ligand
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002500918A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004514412A5 (enExample
Inventor
ニコレット　チャールズ　エイ．
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of JP2004514412A publication Critical patent/JP2004514412A/ja
Publication of JP2004514412A5 publication Critical patent/JP2004514412A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2002500918A 2000-05-31 2001-05-30 卵巣癌のための治療化合物 Pending JP2004514412A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20939100P 2000-05-31 2000-05-31
US22625800P 2000-08-17 2000-08-17
US25700800P 2000-12-20 2000-12-20
PCT/US2001/017456 WO2001092307A2 (en) 2000-05-31 2001-05-30 Therapeutic compounds for ovarian cancer

Publications (2)

Publication Number Publication Date
JP2004514412A true JP2004514412A (ja) 2004-05-20
JP2004514412A5 JP2004514412A5 (enExample) 2005-02-17

Family

ID=27395361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002500918A Pending JP2004514412A (ja) 2000-05-31 2001-05-30 卵巣癌のための治療化合物

Country Status (6)

Country Link
US (1) US20040138135A1 (enExample)
EP (1) EP1355926A2 (enExample)
JP (1) JP2004514412A (enExample)
AU (1) AU2001265189A1 (enExample)
CA (1) CA2410865A1 (enExample)
WO (1) WO2001092307A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115243700A (zh) * 2019-12-11 2022-10-25 美洛德生物医药公司 治疗性细胞组合物及其制造方法和用途

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003050543A1 (en) * 2001-12-05 2003-06-19 Genzyme Corporation Diagnosis of cancer using eif3 as a marker
FR2947716B1 (fr) * 2009-07-10 2011-09-02 Cormove Implant prothetique ameliore

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
AU712820B2 (en) * 1996-03-19 1999-11-18 University Of Virginia Patent Foundation Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytotoxic lymphocytes, and uses therefor
US5789200A (en) * 1996-10-31 1998-08-04 Smithkline Beecham Corporation Human ETS family member, ELF3
AU767391B2 (en) * 1998-10-05 2003-11-06 Genzyme Corporation Peptides related to an IGF-II-R epitope, polynucleotides encoding the peptides, and their use in immunomodulation
AU2001264764A1 (en) * 2000-05-31 2001-12-11 Genzyme Corporation Therapeutic anti-melanoma compounds
DE60109922D1 (de) * 2000-05-31 2005-05-12 Genzyme Corp Therapeutische verbindungen gegen eierstockkrebs

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115243700A (zh) * 2019-12-11 2022-10-25 美洛德生物医药公司 治疗性细胞组合物及其制造方法和用途
JP2023506764A (ja) * 2019-12-11 2023-02-20 マイエロイド・セラピューティクス，インコーポレーテッド 治療用細胞組成物ならびにそれを製造する方法およびその使用

Also Published As

Publication number Publication date
AU2001265189A1 (en) 2001-12-11
US20040138135A1 (en) 2004-07-15
WO2001092307A2 (en) 2001-12-06
CA2410865A1 (en) 2001-12-06
WO2001092307A3 (en) 2003-08-28
EP1355926A2 (en) 2003-10-29

Similar Documents

Publication Publication Date Title
US8029796B2 (en) Therapeutic anti-cytomegalovirus compounds
US6737062B2 (en) Immunogenic compositions
JP2004505607A (ja) 治療的使用のための乳癌抗原ｈｅｒ−２の誘導体
US6861408B2 (en) Therapeutic anti-melanoma compounds
JP2004514412A (ja) 卵巣癌のための治療化合物
US20020182218A1 (en) Therapeutic anti-melanoma compounds
US20020169132A1 (en) Therapeutic anti-melanoma compounds
JP2004506421A (ja) 卵巣癌のための治療化合物

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20050407